• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉考沙胺治疗难治性特发性全面性癫痫。

Lacosamide use in refractory idiopathic primary generalized epilepsy.

机构信息

Virtua Neuroscience, Virtua Health System, Virtua Medical Group, Voorhees, NJ 08043, USA.

出版信息

Epilepsy Behav. 2012 Jan;23(1):79-80. doi: 10.1016/j.yebeh.2011.10.023. Epub 2011 Dec 23.

DOI:10.1016/j.yebeh.2011.10.023
PMID:22197124
Abstract

Treatment of refractory idiopathic primary generalized epilepsy can be very challenging, with limited drug options, especially in young women of childbearing age. Here we describe the cases of two young women with refractory idiopathic primary generalized epilepsy refractory to multiple antiepileptic drugs in monotherapy or combination before achieving a long-term remission with adjunctive lacosamide (LCS) treatment. Larger, randomized prospective studies are necessary to establish the effectiveness of lacosamide in these patients.

摘要

治疗耐药性特发性全面性癫痫非常具有挑战性,可供选择的药物有限,特别是在有生育能力的年轻女性中。在此,我们描述了两例年轻女性的病例,她们在接受多种抗癫痫药物单药或联合治疗后仍未缓解,随后接受了附加左乙拉西坦(LCS)治疗,最终实现了长期缓解。需要更大规模、前瞻性随机研究来确定左乙拉西坦在这些患者中的有效性。

相似文献

1
Lacosamide use in refractory idiopathic primary generalized epilepsy.拉考沙胺治疗难治性特发性全面性癫痫。
Epilepsy Behav. 2012 Jan;23(1):79-80. doi: 10.1016/j.yebeh.2011.10.023. Epub 2011 Dec 23.
2
Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.拉科酰胺作为难治性癫痫患儿辅助治疗的疗效。
J Child Neurol. 2014 Jan;29(1):23-7. doi: 10.1177/0883073812462887. Epub 2012 Nov 8.
3
Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.拉考酰胺用于难治性小儿混合性癫痫:一项前瞻性附加治疗研究。
J Child Neurol. 2012 Apr;27(4):492-5. doi: 10.1177/0883073812436741.
4
Lacosamide treatment of juvenile myoclonic epilepsy.拉考酰胺治疗青少年肌阵挛癫痫。
Seizure. 2012 Apr;21(3):202-4. doi: 10.1016/j.seizure.2011.12.010. Epub 2012 Jan 26.
5
Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.非肠道用拉考酰胺治疗难治性惊厥性癫痫持续状态的成功。
Epilepsia. 2010 Feb;51(2):316-7. doi: 10.1111/j.1528-1167.2009.02256.x. Epub 2009 Aug 8.
6
Lacosamide in patients with pharmacoresistant epilepsy.拉考沙胺治疗耐药性癫痫患者。
Expert Opin Pharmacother. 2012 Oct;13(14):2065-72. doi: 10.1517/14656566.2012.713347. Epub 2012 Aug 8.
7
Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex.拉考酰胺用于治疗结节性硬化症相关难治性癫痫。
Epilepsy Res. 2015 May;112:72-5. doi: 10.1016/j.eplepsyres.2015.02.008. Epub 2015 Feb 16.
8
Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.拉科酰胺作为难治性局灶性癫痫患儿的辅助治疗药物。
Brain Dev. 2014 Jun;36(6):510-5. doi: 10.1016/j.braindev.2013.07.003. Epub 2013 Aug 12.
9
Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.德国一家三级癫痫中心有癫痫患者应用拉科酰胺辅助治疗耐药性局灶性癫痫的 6 个月上市后经验。
Epilepsy Behav. 2009 Nov;16(3):423-5. doi: 10.1016/j.yebeh.2009.07.043. Epub 2009 Sep 19.
10
Lacosamide, a newer antiepileptic.拉科酰胺,一种新型抗癫痫药物。
Neurosciences (Riyadh). 2010 Jan;15(1):3-6.

引用本文的文献

1
Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial.拉科酰胺辅助治疗儿童和青少年难治性局灶性癫痫的疗效:一项开放标签临床试验。
J Res Pharm Pract. 2023 Mar 24;11(3):109-115. doi: 10.4103/jrpp.jrpp_86_21. eCollection 2022 Jul-Sep.
2
Response of focal refractory status epilepticus to lacosamide in an infant.婴儿局灶性耐药性癫痫持续状态对拉科酰胺的反应。
BMJ Case Rep. 2022 Apr 29;15(4):e249948. doi: 10.1136/bcr-2022-249948.
3
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
左乙拉西坦辅助治疗原发性全面强直-阵挛发作的疗效和安全性:一项双盲、随机、安慰剂对照试验。
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1067-1075. doi: 10.1136/jnnp-2020-323524. Epub 2020 Aug 18.
4
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.青少年和成人遗传性全面性癫痫的药物治疗管理。
CNS Drugs. 2020 Feb;34(2):147-161. doi: 10.1007/s40263-020-00698-5.
5
Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study.拉科酰胺用于临床实践中起源于非局灶性的难治性全面强直阵挛发作:一项临床及视频脑电图研究。
Epilepsy Behav Case Rep. 2017 Aug 24;8:63-65. doi: 10.1016/j.ebcr.2017.08.001. eCollection 2017.
6
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.新型抗癫痫药物在局灶性癫痫辅助治疗中的实际应用
CNS Drugs. 2015 Nov;29(11):893-904. doi: 10.1007/s40263-015-0285-4.
7
Status epilepticus developing during lacosamide monotherapy.在拉科酰胺单药治疗期间发生的癫痫持续状态。
BMJ Case Rep. 2015 Jan 27;2015:bcr2014206354. doi: 10.1136/bcr-2014-206354.
8
Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.静脉注射拉考酰胺辅助治疗难治性癫痫持续状态的安全性和有效性:一项对照队列研究。
CNS Drugs. 2013 Apr;27(4):321-9. doi: 10.1007/s40263-013-0049-y.